FDA will not subject device data systems to premarket approval

02/14/2011 | Health Data Management

The FDA is set to unveil today the final rule that would exempt medical device data systems from premarket approval by reclassifying such devices from the Class III category to Class I. In its final rule, the agency discussed the functions of an MDDS and stated the differences between an MDDS and a patient monitoring system.

View Full Article in:

Health Data Management

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ